These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15819472)

  • 21. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the epidermal growth factor receptor specific transcriptome: effect of receptor expression level and an activating mutation.
    Pedersen MW; Pedersen N; Damstrup L; Villingshøj M; Sønder SU; Rieneck K; Bovin LF; Spang-Thomsen M; Poulsen HS
    J Cell Biochem; 2005 Oct; 96(2):412-27. PubMed ID: 16075456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal transformation in epithelial ovarian tumor cells expressing epidermal growth factor receptor variant III.
    Zeineldin R; Rosenberg M; Ortega D; Buhr C; Chavez MG; Stack MS; Kusewitt DF; Hudson LG
    Mol Carcinog; 2006 Nov; 45(11):851-60. PubMed ID: 16788982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crosstalk between androgen receptor and epidermal growth factor receptor-signalling pathways: a molecular switch for epithelial cell differentiation.
    Léotoing L; Manin M; Monté D; Baron S; Communal Y; Lours C; Veyssière G; Morel L; Beaudoin C
    J Mol Endocrinol; 2007 Aug; 39(2):151-62. PubMed ID: 17693613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of Epidermal Growth Factor Receptor variant III in laryngeal carcinoma tissues.
    Yang B; Chen J; Zhang X; Cao J
    Auris Nasus Larynx; 2009 Dec; 36(6):682-7. PubMed ID: 19427146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines.
    Paliouras M; Diamandis EP
    Biol Chem; 2008 Jun; 389(6):773-80. PubMed ID: 18627304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclooxygenase-2 expression is dependent upon epidermal growth factor receptor expression or activation in androgen independent prostate cancer.
    Jia RP; Xu LW; Su Q; Zhao JH; Li WC; Wang F; Xu Z
    Asian J Androl; 2008 Sep; 10(5):758-64. PubMed ID: 18645679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer: a model of integration of genomic and non-genomic effects of the androgen receptor in cell lines model.
    Bonaccorsi L; Nosi D; Quercioli F; Formigli L; Zecchi S; Maggi M; Forti G; Baldi E
    Steroids; 2008 Oct; 73(9-10):1030-7. PubMed ID: 18358509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the androgen receptor in a benign prostate tissue-derived human prostate epithelial cell line: RC-165N/human telomerase reverse transcriptase.
    Kim KH; Dobi A; Shaheduzzaman S; Gao CL; Masuda K; Li H; Drukier A; Gu Y; Srikantan V; Rhim JS; Srivastava S
    Prostate Cancer Prostatic Dis; 2007; 10(1):30-8. PubMed ID: 17075604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
    Wu JD; Haugk K; Woodke L; Nelson P; Coleman I; Plymate SR
    J Cell Biochem; 2006 Oct; 99(2):392-401. PubMed ID: 16639715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy.
    Rosner IL; Ravindranath L; Furusato B; Chen Y; Gao C; Cullen J; Sesterhenn IA; McLeod DG; Srivastava S; Petrovics G
    Urology; 2007 Dec; 70(6):1225-9. PubMed ID: 18158066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
    Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermal growth factor receptor (EGFR) expression in prostatic adenocarcinoma after hormonal therapy: a fluorescence in situ hybridization and immunohistochemical analysis.
    Marks RA; Zhang S; Montironi R; McCarthy RP; MacLennan GT; Lopez-Beltran A; Jiang Z; Zhou H; Zheng S; Davidson DD; Baldridge LA; Cheng L
    Prostate; 2008 Jun; 68(9):919-23. PubMed ID: 18409189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermal growth factor receptor activation in prostate cancer by three novel missense mutations.
    Cai CQ; Peng Y; Buckley MT; Wei J; Chen F; Liebes L; Gerald WL; Pincus MR; Osman I; Lee P
    Oncogene; 2008 May; 27(22):3201-10. PubMed ID: 18193092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.
    Chen SY; Cai C; Fisher CJ; Zheng Z; Omwancha J; Hsieh CL; Shemshedini L
    Oncogene; 2006 Nov; 25(54):7212-23. PubMed ID: 16732317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer.
    Cano P; Godoy A; Escamilla R; Dhir R; Onate SA
    Cancer Res; 2007 Jan; 67(2):511-9. PubMed ID: 17234758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of androgen and estrogen related proteins in normal weight and obese prostate cancer patients.
    Gross M; Ramirez C; Luthringer D; Nepomuceno E; Vollmer R; Burchette J; Freedland SJ
    Prostate; 2009 Apr; 69(5):520-7. PubMed ID: 19107851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.
    Sok JC; Coppelli FM; Thomas SM; Lango MN; Xi S; Hunt JL; Freilino ML; Graner MW; Wikstrand CJ; Bigner DD; Gooding WE; Furnari FB; Grandis JR
    Clin Cancer Res; 2006 Sep; 12(17):5064-73. PubMed ID: 16951222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical study of the expression of epidermal growth factor receptor in benign prostatic hypertrophy, prostatic intraepithelial neoplasia and prostatic carcinoma.
    Rana S; Sen R; Kalra R; Arora B; Sharma P; Gahlawat S
    Indian J Pathol Microbiol; 2006 Oct; 49(4):495-9. PubMed ID: 17183836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutant epidermal growth factor receptor in benign, borderline, and malignant ovarian tumors.
    Steffensen KD; Waldstrøm M; Olsen DA; Corydon T; Lorentzen KA; Knudsen HJ; Jeppesen U; Brandslund I; Jakobsen A
    Clin Cancer Res; 2008 Jun; 14(11):3278-82. PubMed ID: 18519753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.